Skip to content
Open access

Automated zonal-rotor CsCl ultracentrifugation with ÄKTA-based fractionation removes empty and intermediate AAV capsids

Sep 2026 · Molecular therapy. Advances · Vol 34 · 0 citations · 19 references
Medicine

Abstract

Recombinant adeno-associated virus (AAV) preparations contain heterogeneous full, empty, and intermediate capsids. Although anion-exchange chromatography is scalable, it does not always resolve these populations, particularly intermediate capsids. A workflow integrated zonal-rotor cesium chloride (CsCl) density-gradient ultracentrifugation with ÄKTA-based loading, inline monitoring, unloading, and fraction collection. SW41Ti swing-bucket experiments defined the empirical 1,240–1,360 mg/cm3 AAV density range and identified a two-layer CsCl configuration for transfer to a 1.65-L Ti-15 zonal rotor. The same process was demonstrated with AAV8-X and AAV9-Y. The AAV8-X full fraction contained 95.5% full and 0.4% empty capsids; the AAV9-Y full fraction contained 91.8% full capsids, with no empty capsids detected by sedimentation velocity analytical ultracentrifugation (SV-AUC). Vector-genome-based full-fraction recoveries were 78.1% and 93.4%, respectively. On an equal-capsid basis, the AAV8-X intermediate fraction showed an SV40-targeted quantitative polymerase chain reaction (qPCR) signal equivalent to 48.2% of the full fraction. Separately, a Huh-7 assay tested the intermediate fraction at a higher capsid input than the full fraction, yielding approximately 4% of full-fraction X-gene mRNA expression. Thus, the intermediate fraction retained genome-targeted qPCR signal but showed limited expression under the tested conditions. This automated ÄKTA-coupled zonal CsCl workflow provides a scalable, high-resolution polishing operation for separating AAV capsid populations.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.